Diabetes, Vol 46, Issue 3 494-501, Copyright © 1997 by American Diabetes Association

ARTICLES

Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index

T Hansen, CB Andersen, SM Echwald, SA Urhammer, JO Clausen, H Vestergaard, D Owens, L Hansen and O Pedersen
Steno Diabetes Center and Hagedorn Research Institute, Glostrup University Hospital, Copenhagen, Denmark.

Phosphatidylinositol 3-kinase (PI3-K) may regulate the basal plasma membrane glucose transporter recycling and the organization of the transporter intracellular pool in addition to being an insulin signal for translocation of glucose transporters to the plasma membrane. The objectives of the present study were to examine for genetic variability in the human regulatory p85alpha subunit of PI3-K, to look for an association between gene variants and NIDDM in a case-control study, and to relate identified variability to potential changes in whole-body insulin sensitivity and glucose turnover in a phenotype study. Single-strand conformational polymorphism and heteroduplex analysis of the coding region of the regulatory p85alpha subunit in cDNA isolated from human muscle tissue from 70 insulin-resistant NIDDM patients and 12 control subjects revealed three silent polymorphisms and a missense mutation at nucleotide position 1020 (G-->A), changing a Met to Ile at codon 326. Using allele-specific oligohybridization, we found a similar allelic frequency of the codon 326Met-->Ile variant in 404 NIDDM patients (0.15 [95% CI 0.13-0.17]) and 224 matched glucose tolerant control subjects (0.16 [0.13-0.19]). In a random sample of 380 unrelated healthy young Caucasians aged 18-32 years, in whom we have performed a tolbutamide modified intravenous glucose tolerance test, we identified 263 wildtype subjects, 109 heterozygous subjects, and 8 subjects homozygous for the codon 326 variant (allelic frequency = 0.16 [0.13-0.19]). No difference in glucose disappearance constant (KG), insulin sensitivity index (SI), and glucose effectiveness (SG) was observed between wildtype and heterozygous subjects. However, compared with the combined values for wildtype and heterozygous carriers, KG was reduced by 40% (P = 0.004) and SG by 23% (P = 0.03) in homozygous carriers of the p85alpha variant. Moreover, in homozygous carriers, a 32% reduction was found in SI (P = 0.08). In conclusion, a codon 326Met-->Ile variant in the gene encoding the PI3-K p85alpha regulatory subunit is found in 31% of a random sample of young healthy Caucasians. About 2% of the subjects in this population carry the gene variant in its homozygous form, and these carriers are characterized by significant reductions in whole-body glucose effectiveness and intravenous glucose disappearance constant. In itself, the gene variant does not confer an increased risk of diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G Andersen, L Wegner, K Yanagisawa, C S Rose, J Lin, C Glumer, T Drivsholm, K Borch-Johnsen, T Jorgensen, T Hansen, et al. Evidence of an association between genetic variation of the coactivator PGC-1{beta} and obesity J. Med. Genet., May 1, 2005; 42(5): 402 - 407. [Abstract] [Full Text] [PDF]

				A. J. McGettrick, E. P. Feener, and C. R. Kahn Human Insulin Receptor Substrate-1 (IRS-1) Polymorphism G972R Causes IRS-1 to Associate with the Insulin Receptor and Inhibit Receptor Autophosphorylation J. Biol. Chem., February 25, 2005; 280(8): 6441 - 6446. [Abstract] [Full Text] [PDF]

				B. D. Chiodini and C. M. Lewis Meta-Analysis of 4 Coronary Heart Disease Genome-Wide Linkage Studies Confirms a Susceptibility Locus on Chromosome 3q Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1863 - 1868. [Abstract] [Full Text] [PDF]

				G. Andersen, C. S. Rose, Y. H. Hamid, T. Drivsholm, K. Borch-Johnsen, T. Hansen, and O. Pedersen Genetic Variation of the GLUT10 Glucose Transporter (SLC2A10) and Relationships to Type 2 Diabetes and Intermediary Traits Diabetes, September 1, 2003; 52(9): 2445 - 2448. [Abstract] [Full Text] [PDF]

				A. E. Paradis, P. W. Kantoff, E. Giovannucci, M. J. Stampfer, and J. Ma Association between the Met326Ile Polymorphism of the p85{alpha} Regulatory Subunit of Phosphatidylinositol 3-Kinase and Prostate Cancer Risk: A Prospective Study Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 172 - 173. [Full Text] [PDF]

				M. Kossila, J. Pihlajamaki, P. Karkkainen, R. Miettinen, P. Kekalainen, I. Vauhkonen, S. Yla-Herttuala, and M. Laakso Promoter Polymorphisms -359T/C and -303A/G of the Catalytic Subunit p110{beta} Gene of Human Phosphatidylinositol 3-Kinase Are Not Associated With Insulin Secretion or Insulin Sensitivity in Finnish Subjects Diabetes Care, January 1, 2003; 26(1): 179 - 182. [Abstract] [Full Text] [PDF]

				S. E. Nikoulina, T. P. Ciaraldi, L. Carter, S. Mudaliar, K. S. Park, and R. R. Henry Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4307 - 4314. [Abstract] [Full Text] [PDF]

				A. M. Møller, N. M. Jensen, J. Pildal, T. Drivsholm, K. Borch-Johnsen, S. A. Urhammer, T. Hansen, and O. Pedersen Studies of Genetic Variability of the Glucose Transporter 2 Promoter in Patients with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2181 - 2186. [Abstract] [Full Text]

				L. T. Dalgaard, T. I. A. Sørensen, T. Drivsholm, K. Borch-Johnsen, T. Andersen, T. Hansen, and O. Pedersen A Prevalent Polymorphism in the Promoter of the UCP3Gene and Its Relationship to Body Mass Index and Long Term Body Weight Change in the Danish Population J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1398 - 1402. [Abstract] [Full Text]

				L. Hansen, B. Zethelius, L. Berglund, R. Reneland, T. Hansen, C. Berne, H. Lithell, B. A. Hemmings, and O. Pedersen In Vitro and In Vivo Studies of a Naturally Occurring Variant of the Human p85{alpha} Regulatory Subunit of the Phosphoinositide 3-Kinase: Inhibition of Protein Kinase B and Relationships With Type 2 Diabetes, Insulin Secretion, Glucose Disappearance Constant, and Insulin Sensitivity Diabetes, March 1, 2001; 50(3): 690 - 693. [Abstract] [Full Text]

				S. I. McFarlane, M. Banerji, and J. R. Sowers Insulin Resistance and Cardiovascular Disease J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 713 - 718. [Full Text]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				K. Almind, L. Delahaye, T. Hansen, E. Van Obberghen, O. Pedersen, and C. R. Kahn Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha PNAS, February 19, 2002; 99(4): 2124 - 2128. [Abstract] [Full Text] [PDF]